Bioasis Technologies Inc. V.BTI

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

TSXV:BTI - Post by User

Bioasis Technologies Inc. > Enjoy The Back And Forth Guys

<< Previous

Bullboard Posts

Next >>

Comment by craighenryon Dec 15, 2022 8:38pm

90 Views

Post# 35174814

RE:RE:RE:RE:RE:RE:RE:Enjoy The Back And Forth Guys

JDavenport wrote: Yes, narmac, I mostly have canvassed the dozen or so I've spoken to since this all started.

All want to vote down the deal, but they all know that they don't know enough yet to do it with confidence. That's why I asked the questions this morning in that larger post I made.

If DrDR doesn't have an answer, or has the wrong answer, then thought will have to be given to what actions are possible.

If Bioasis turns out to be in default before a vote can take place, then maybe the TSX would be interested in the fact that a meaningful vote cannot be taken by shareholders, that DrDR has already caused shareholders to lose xB3. Other regulators may also be interested in that.

So, I think we need more information.

jd